by AACR
Findings from the Phase 3 AURIGA trial support the use of lenalidomide plus daratumumab (D-R) over lenalidomide alone (R) as post-transplant maintenance therapy for patients with newly diagnosed...
by ASTCT Advocacy Update
Mark your calendars for ASTCT's Government Relations Spotlight Session titled "Inside the Administration - Insight into the Federal Government and How We Can Make a Lasting Impact"...
by Alex Kadhim
Researchers at SickKids Hospital and McMaster University have developed a novel chimeric antigen receptor (CAR) T-cell therapy targeting ROBO1, a protein involved in axonal guidance, for the...
by Blood
Based on results from the OUTREACH study, outpatient monitoring appears to be both safe and effective for patients with relapsed/refractory large B-cell lymphoma who undergo lisocabtagene...
by Dr. Corey Cutler, MD, MPH
In the November President's Message, Dr. Corey Cutler, MD, MPH, brings a look back at an eventful season packed with progress and collaboration.
by Nature Medicine
Researchers report that while autologous chimeric antigen receptor (CAR) T-cell manufacturing is possible in the setting of acute myeloid leukemia (AML), myeloid-supporting cytokines released...